Clinical Trial: Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Single-Center, Masked, Randomized Study Comparing Two Marketed Ocular Anti-Allergy Medications in the Cat Room Model

Brief Summary: The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis.

Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.

Current Primary Outcome: Change in Ocular Itch Score From Baseline [ Time Frame: 0 hours, 12 hours ]

Ocular itch was measured on a 0 (none) to 4 (severe itch with continual desire to rub eyes) scale. Negative values for change from baseline represent favorable outcomes.


Original Primary Outcome: Change in Ocular Itch Score From Baseline [ Time Frame: 1 day ]

Current Secondary Outcome: Ocular Comfort Score at 12 Hours [ Time Frame: 12 hours ]

Ocular comfort was measured on a 0 (more uncomfortable) to 10 (more comfortable) scale.


Original Secondary Outcome: Ocular comfort score [ Time Frame: 1 day ]

Information By: Merck Sharp & Dohme Corp.

Dates:
Date Received: September 20, 2007
Date Started: October 2007
Date Completion:
Last Updated: April 27, 2015
Last Verified: April 2015